Institutional Ownership
Atossa Therapeutics Inc
CUSIP 04962H704COMATOSQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
28
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ameriprise Financial Inc | 255.1K | $1.34M |
| 2 | Blackrock, Inc. | 133.2K | $700.5K |
| 3 | Renaissance Technologies LLC | 109.0K | $573.4K |
| 4 | Geode Capital Management, LLC | 97.1K | $510.7K |
| 5 | Ubs Group AG | 92.0K | $484.1K |
| 6 | Millennium Management LLC | 66.7K | $351.0K |
| 7 | State Street Corp | 39.8K | $209.1K |
| 8 | Northern Trust Corp | 19.2K | $101.1K |
| 9 | Morgan Stanley | 16.2K | $85.2K |
| 10 | Jones Financial Companies Lllp | 2.1K | $9.7K |